Integrated GNPS Molecular Networking and Network Pharmacology Uncover Methylophiopogonanone B as a Novel Anti‐Inflammatory Agent From <scp> <i>Polygonatum cyrtonema</i> </scp> Hua Targeting the SRC‐PI3K‐Akt Pathway

Inflammation is a defensive immune response to tissue damage or infection. Polygonatum cyrtonema Hua (P. cyrtonema Hua, PCH) is bioactive on immune homeostasis due to its rich components and reportedly plays a therapeutic role in the treatment and prevention of diabetes. Flavonoids of PCH possess anti-inflammatory properties, but their molecular mechanisms remain elusive. Here, chemical profiling of key flavonoids was conducted using UPLC-QTOF-MS/MS and the Global Natural Products Social Molecular Networking (GNPS) platform. Network pharmacology predicted potential targets and pathways, validated by molecular docking, surface plasmon resonance (SPR), and western blotting. Totally, 67 compounds were identified, with methylophiopogonanone B (MOB) as the key bioactive flavonoid. Although MOB's anti-inflammatory activity has been previously noted, the present study provides the first evidence that this effect may be mediated through targeting SRC and modulating the PI3K/AKT signaling axis. Core therapeutic targets were identified as SRC, TNF, and AKT1 by topological analysis of network pharmacology. Molecular docking and SPR confirmed strong MOB-SRC binding affinity. Western blotting revealed MOB dose-dependently inhibited LPS-induced phosphorylation of SRC, PI3K, and AKT1, without altering total protein levels. Furthermore, MOB significantly suppressed the phosphorylation of NF-κB pathway proteins IκB and p65, confirming the involvement of NF-κB as a downstream effector. In conclusion, this study integrates chemical profiling and network pharmacology with experimental validation to define the flavonoid composition of PCH, and is the first to implicate the SRC-PI3K-Akt pathway in MOB's anti-inflammatory action and providing novel evidence supporting the mechanism and use of PCH in contemporary diabetes treatment.

Authors

Institutions

Publication Details

Journal
Biomedical Chromatography
Published
2026-07-22
DOI
https://doi.org/10.1002/bmc.70570
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Integrated GNPS Molecular Networking and Network Pharmacology Uncover Methylophiopogonanone B as a Novel Anti‐Inflammatory Agent From Polygonatum cyrtonema Hua Targeting the SRC‐PI3K‐Akt Pathway

Jun Han, Xu Shixia, Di Cao, Xuefeng Hou et al.
Biomedical Chromatography
Computational Drug Discovery Methods
article

Integrated GNPS Molecular Networking and Network Pharmacology Uncover Methylophiopogonanone B as a Novel Anti‐Inflammatory Agent From Polygonatum cyrtonema Hua Targeting the SRC‐PI3K‐Akt Pathway

Jun Han, Xu Shixia, Di Cao, Xuefeng Hou, Huidan Huang, Lizhen Yu, Yi Han, Baobao Yao, Renbin Li
article en

Abstract

Inflammation is a defensive immune response to tissue damage or infection. Polygonatum cyrtonema Hua (P. cyrtonema Hua, PCH) is bioactive on immune homeostasis due to its rich components and reportedly plays a therapeutic role in the treatment and prevention of diabetes. Flavonoids of PCH possess anti-inflammatory properties, but their molecular mechanisms remain elusive. Here, chemical profiling of key flavonoids was conducted using UPLC-QTOF-MS/MS and the Global Natural Products Social Molecular Networking (GNPS) platform. Network pharmacology predicted potential targets and pathways, validated by molecular docking, surface plasmon resonance (SPR), and western blotting. Totally, 67 compounds were identified, with methylophiopogonanone B (MOB) as the key bioactive flavonoid. Although MOB's anti-inflammatory activity has been previously noted, the present study provides the first evidence that this effect may be mediated through targeting SRC and modulating the PI3K/AKT signaling axis. Core therapeutic targets were identified as SRC, TNF, and AKT1 by topological analysis of network pharmacology. Molecular docking and SPR confirmed strong MOB-SRC binding affinity. Western blotting revealed MOB dose-dependently inhibited LPS-induced phosphorylation of SRC, PI3K, and AKT1, without altering total protein levels. Furthermore, MOB significantly suppressed the phosphorylation of NF-κB pathway proteins IκB and p65, confirming the involvement of NF-κB as a downstream effector. In conclusion, this study integrates chemical profiling and network pharmacology with experimental validation to define the flavonoid composition of PCH, and is the first to implicate the SRC-PI3K-Akt pathway in MOB's anti-inflammatory action and providing novel evidence supporting the mechanism and use of PCH in contemporary diabetes treatment.

Biomedical ChromatographyVol. 40(9)
Wannan Medical College (CN), Anhui University of Traditional Chinese Medicine (CN), Honghu Hospital of Traditional Chinese Medicine (CN)
Good health and well-being
Openalex Percentile: Top 6%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.